Mercy's Drs. Sergey Kantsevoy and Paul Thuluvath Acclaimed As Among "Top 2 Percent of World's Scientist"
In a recent issue of PLOS Biology, a monthly peer-reviewed scientific journal covering all aspects of biology, a Stanford scientist ranked and published the top 2% of scientists (~150,000) from all fields of science based on their publication records, impact factor of the journal and the citation rates by other prominent investigators. Mercy’s Sergey V. Kantsevoy, M.D. (top 0.5% in the world) and Paul J. Thuluvath, M.D. (top 0.15% in the world) of The Institute for Digestive Health and Liver Disease (IDHLD) were noted (and ranked very high) among this 2% of all world scientists from all disciplines of science.
Dr. Kantsevoy is Director of The Center for Therapeutic Endoscopy, part of the IDHLD. A specialist and regional authority in interventional endoscopy and endoscopic ultrasound, he is Board Certified in Gastroenterology and Hepatology. Dr. Kantsevoy is a seasoned lecturer and has been invited to medical conferences in China, Germany, Puerto Rico, Hong Kong and the United States. He is also a well published author and has produced decades of peer-reviewed scientific articles for such publications as:
· Clinical Gastroenterology and Hepatology
· Digestive Diseases and Sciences
· Gastrointestinal Endoscopy
· Surgical Endoscopy
He is a co-author of several books on digestive disorders, over 20 book chapters and has medical patents on procedures and treatment systems in endoscopic procedures. Dr. Kantsevoy is internationally recognized as a Fellow of the Japan Gastroenterological Endoscopy Society (FJGES) - a prestigious professional designation for gastroenterologists with expertise in endoscopic procedures.
Paul J. Thuluvath, M.D., is the Medical Director of The Institute for Digestive Health & Liver Disease at the Mercy Medical Center, and the Director of the University of Maryland Advanced Hepatology Network. He is an authority on liver and biliary diseases and has published more than 280 peer reviewed papers, 30 book chapters and edited six textbooks in the field of gastroenterology and liver diseases. He had served on the editorial board of numerous journals including Hepatology, Liver Transplant, JCEH and Gastrointestinal Endoscopy. Dr. Thuluvath has a specialized research interest in liver transplantation outcomes.
Founded in 1874 in downtown Baltimore by the Sisters of Mercy, Mercy Medical Center is a 183-licensed bed acute care university-affiliated teaching hospital. Mercy has been recognized as a top Maryland hospital by U.S. News & World Report; a Top 100 hospital for Women’s Health & Orthopedics by Healthgrades; is currently A-rated for Hospital Safety (Leapfrog Group), and is recognized by the American Nurses Credentialing Center as a Magnet Hospital. Mercy Medical Center is part of Mercy Health Services (MHS), the parent of Mercy’s primary care and specialty care physician enterprise, known as Mercy Personal Physicians, which employs more than 200 providers with locations in Baltimore, Lutherville, Overlea, Glen Burnie, Columbia and Reisterstown. For more information about Mercy, visit www.mdmercy.com, MDMercyMedia on Facebook, Twitter, or call 1-800-MD-Mercy.